Patent strategies in the antisense oligonucleotide based therapeutic approach

Expert Opinion on Therapeutic Patents

Volumn 7, Issue 10, 1997, Pages 1175-1182

  Craig, A ^a   Vanstone, D ^a   Agrawal, S ^a  

^a HYBRIDON INC   (United States)

Author keywords

Antisense oligonucleotides; Composition of matter; Formulations; Oligonucleotide manufacture; Oligonucleotide modifications; RNase H, 2' O substituted ribonuclease

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGORIBONUCLEOTIDE;

DRUG FORMULATION; DRUG MANUFACTURE; PATENT; REVIEW;

EID: 0030884399     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.7.10.1175     Document Type: Review

References (135)